nanotechnolog
expand
area
studi
potenti
pivot
applic
disciplin
medicin
new
biomed
activ
molecul
strategi
continu
develop
one
princip
drawback
applic
new
therapi
difficulti
cross
membran
repres
main
physiolog
barrier
bodi
live
cell
membran
select
permeabl
allow
select
intern
substanc
gener
form
highli
imperm
barrier
polar
charg
molecul
repres
obstacl
drug
deliveri
limit
absorpt
specif
rout
mechan
virus
provid
attract
suggest
develop
target
drug
carrier
evolv
natur
deliv
genom
host
cell
high
fidel
detail
understand
viru
structur
mechan
entri
mammalian
cell
facilit
develop
analysi
virusbas
materi
medic
applic
membran
repres
physiolog
barrier
bodi
live
cell
also
cellular
organel
need
membran
order
maintain
protect
extern
microenvironment
damag
plasma
membran
compos
tightli
pack
lipid
molecul
includ
phospholipid
sphingolipid
sterol
interdispers
protein
act
structur
element
transport
nutrient
environment
monitor
membran
select
permeabl
allow
penetr
substanc
other
particular
form
highli
imperm
barrier
polar
charg
molecul
repres
physic
barrier
drug
absorpt
limit
absorpt
specif
rout
mechan
therefor
one
key
requir
diagnosi
therapi
chronic
diseas
cancer
effici
deliveri
imag
agent
drug
target
site
novel
deliveri
tool
strongli
requir
increas
specif
therapeut
index
respect
varieti
biodrug
includ
peptid
protein
produc
commerci
scale
intracellularli
deliv
exert
therapeut
action
insid
cytoplasm
onto
specif
organel
cell
poorli
intern
drug
cross
membran
rather
ineffici
mani
treatment
activ
drug
concentr
target
diseas
site
suffici
gener
therapeut
effect
moreov
larg
amount
drug
also
deliv
normal
tissu
could
result
sever
side
effect
low
therapeut
index
anoth
import
exampl
gene
therapi
latter
method
treatment
prevent
diseas
use
gene
provid
patient
genet
inform
necessari
produc
specif
therapeut
protein
requir
correct
modul
diseas
use
plasmid
encod
protein
modul
target
use
interfer
method
small
interfer
rna
sirna
microrna
key
problem
overcom
gene
therapi
deliveri
sirna
nucleic
acid
specif
locat
within
bodi
low
plasma
halflif
nucleic
acid
sever
method
exist
intracellular
deliveri
drug
oligonucleotid
choic
strictli
depend
natur
drug
specif
place
reach
method
present
advantag
disadvantag
deliveri
vector
promis
tool
cellular
uptak
vitro
vivo
nontox
nonimmunogen
paolo
grieco
graduat
medicin
chemistri
univers
napl
federico
ii
itali
obtain
phd
work
solidphas
peptid
synthesi
postdoctor
fellow
depart
chemistri
biochemistri
univers
arizona
work
develop
peptid
peptidomimet
ligand
activ
melanocortin
receptor
appoint
associ
professor
medicin
chemistri
univers
napl
federico
ii
sinc
full
professor
medicin
chemistri
depart
pharmaci
univers
napl
federico
ii
author
scientif
public
intern
journal
sever
patent
discov
new
molecul
potenti
therapeut
agent
diagnost
applic
giancarlo
morelli
full
professor
chemistri
univers
napl
federico
ii
napoli
itali
head
research
center
bioactiv
peptid
research
interest
devot
develop
diagnost
therapeut
agent
base
bioactiv
peptid
also
focus
develop
new
nanovector
peptid
modifi
supramolecular
aggreg
diagnosi
therapi
nanomedicin
uptak
mechan
also
play
key
role
mani
vector
demonstr
involv
essenti
endocyt
mechan
howev
endosom
entrap
limit
activ
fact
small
quantiti
agent
escap
environ
achiev
specif
desir
biolog
site
action
therefor
fundament
exploit
novel
moieti
target
system
use
differ
intern
mechan
repres
altern
macromolecul
technolog
interest
plasmid
may
incorpor
anion
neutral
liposom
protect
vivo
degrad
enhanc
intracellular
deliveri
differ
strategi
develop
order
enhanc
interact
subsequ
intern
nanocarri
target
cell
light
phsensit
liposom
fusogen
acid
ph
thu
use
facilit
endosom
disrupt
subsequ
releas
plasmid
cytoplasm
usual
consist
dioleoylphosphatidylethanolamin
lipophil
anion
compon
anoth
strategi
develop
proteoliposom
incorpor
viral
protein
fusogen
peptid
nuclear
protein
nuclear
local
peptid
induc
fusion
liposom
cell
membran
facilit
drug
releas
transport
cytoplasm
detail
cation
lipid
interact
electrostat
neg
charg
phosphat
backbon
dna
neutral
charg
promot
condens
dna
compact
structur
usual
cation
lipid
mix
zwitterion
neutral
colipid
dioleoylphosphatidylethanolamin
cholesterol
respect
form
liposom
micel
cation
lipidbas
gene
deliveri
system
lack
target
specif
result
low
transfect
effici
certain
tissu
due
interfer
among
cation
lipidbind
macromolecul
either
circul
extracellular
matrix
anoth
import
concern
treatment
human
diseas
cross
physiolog
anatom
barrier
bloodbrain
barrier
bbb
fact
treatment
neurolog
disord
remain
limit
inabl
therapeut
agent
effect
cross
bbb
protect
brain
invad
organ
unwant
substanc
repres
obstacl
penetr
drug
strategi
transport
drug
insid
cn
determin
disrupt
anatom
textur
bbb
thu
impair
natur
function
particular
effect
deliveri
approach
cautious
assess
consid
impact
overal
protect
function
bbb
moment
deliveri
strategi
across
bbb
divid
invas
noninvas
approach
invas
approach
involv
temporari
disrupt
bbb
intraventricular
intracerebr
administr
wherea
noninvas
approach
involv
intraven
administr
drug
coupl
carrier
undergo
receptor
adsorptivemedi
transcytosi
intranas
rout
base
target
deliveri
drug
intend
site
action
brain
repres
one
promis
noninvas
approach
overcom
bbb
combin
advantag
brain
target
high
incorpor
capac
reduct
side
effect
circumvent
multidrug
efflux
system
virus
nanotechnolog
devic
exampl
intracellular
deliveri
exampl
nucleic
acid
deliveri
illumin
fabric
cellpenetr
drug
deliveri
system
case
effort
address
introduc
foreign
nucleic
acid
pharmacolog
weapon
cell
deriv
use
suggest
understand
viru
infect
process
fact
viral
carrier
adenovir
vector
retrovirallentivir
vector
use
first
time
past
decad
bind
host
introduc
genet
organ
materi
target
cell
thu
mimick
infecti
process
viral
vector
prepar
remov
viral
genom
substitut
therapeut
oligonucleotid
viral
husk
deliveri
system
show
rel
high
transfect
effici
vitro
vivo
rais
sever
clinic
safeti
administr
concern
latter
push
research
nonvir
carrier
limit
side
effect
compar
attenu
virus
light
use
viral
compon
favor
intracellular
uptak
nanoparticl
could
use
drug
deliveri
strategi
therefor
spark
increas
knowledg
structur
life
cycl
sever
virus
mani
virusmimick
nonvir
carrier
develop
therapeut
applic
present
mini
review
briefli
describ
viral
properti
exploit
intracellular
deliveri
use
viralderiv
peptid
modular
viralderiv
protein
assembl
viru
nanoparticl
vnp
virus
one
entranc
door
gain
access
bodi
potenti
host
immedi
overcom
follow
challeng
penetr
mucu
layer
ii
move
bloodstream
iii
replic
live
host
cell
replic
involv
deliveri
viral
genom
host
cell
use
intracellular
machin
arriv
proxim
cell
infect
critic
moment
viral
infecti
cycl
follow
cellular
receptor
bind
ii
intern
iii
uncoat
releas
viral
nucleic
acid
proper
site
replic
figur
depend
differ
complex
viral
particl
variou
strategi
mediat
effici
infect
result
physic
interact
cell
virus
critic
barrier
repres
complex
membran
system
surround
resid
within
host
cell
consist
follow
plasma
membran
ii
rather
dens
cytoplasm
molecular
traffic
highli
restrict
regul
iii
membran
must
cross
order
access
site
viral
replic
assembl
virus
consist
rna
dna
genom
surround
either
multipl
copi
capsid
protein
nonenvelop
virus
capsid
protein
lipid
membran
envelop
virus
size
anim
virus
rang
approxim
nm
nm
depend
dimens
structur
virus
acquir
differ
strategi
use
control
cell
function
nowaday
overal
pictur
entri
anim
viru
host
cell
becom
increasingli
complet
fact
studi
perform
sever
virus
differ
cellular
system
shed
light
basic
mechan
viral
entri
although
fine
molecular
detail
interfac
viru
cell
surfac
interact
quit
complex
highli
variabl
pathway
allow
virus
reach
site
penetr
seem
limit
fact
endocyt
mechan
involv
bind
cell
surfac
wide
varieti
differ
protein
lipid
carbohydr
use
virus
molecul
gener
consid
attach
factor
simpli
enabl
virus
bind
concentr
cell
surfac
interact
cell
surfac
involv
real
receptor
addit
bind
activ
promot
entri
cell
mediat
conform
chang
viru
particl
trigger
signal
pathway
promot
overal
infecti
process
thu
first
highli
specif
step
viral
infect
bind
receptor
present
plasma
membran
may
either
primari
receptor
coreceptor
latter
lower
bind
affin
involv
primari
receptor
order
enhanc
bind
strength
virus
abl
penetr
directli
cell
surfac
fuse
envelop
plasma
membran
speci
retrovirida
paramyxovirida
herpesvirida
recognit
specif
cell
surfac
receptor
trigger
fusion
envelop
plasma
membran
best
character
fusion
mechan
cellular
uptak
mediat
two
glycoprotein
name
bind
primari
receptor
gener
conform
chang
determin
interact
chemokin
coreceptor
exposur
hydrophob
fusion
peptid
present
ntermin
region
insert
plasma
membran
drive
membran
fusion
anoth
exampl
repres
herp
simplex
viru
type
subfamili
undergo
fusion
event
follow
engag
glycoprotein
gb
gd
cellular
receptor
henc
fusion
viral
envelop
plasma
membran
lead
releas
capsid
cytoplasm
virus
envelop
nonenvelop
undergo
endocytosi
fundament
cellular
process
involv
uptak
mani
macromolecul
virus
use
sever
endocyt
rout
cellular
intern
caveolar
clathrindepend
caveolaeindepend
clathrinmedi
endocytosi
ligand
bind
specif
receptor
determin
cluster
ligandreceptor
complex
coat
pit
plasma
membran
invagin
pinch
membran
form
intracellular
clathrinco
vesicl
depolymer
fusion
result
format
late
endosom
fuse
lysosom
cargo
degrad
although
lysosom
repres
culdesac
mani
molecul
util
cell
intern
rout
virus
develop
abil
avoid
lysosom
degrad
escap
cytosol
therefor
penetr
event
follow
endosom
intern
necessari
deliveri
cytosol
case
envelop
virus
penetr
invari
involv
membran
fusion
similarli
alreadi
describ
fusion
plasma
membran
mediat
specif
viral
glycoprotein
main
differ
two
mode
fusion
insid
endosom
virus
fuse
envelop
limit
membran
endocyt
vacuol
lumin
side
therefor
membran
fusion
repres
common
step
entri
envelop
virus
regardless
chosen
rout
also
essenti
ubiquit
mechan
cellular
event
viral
fusion
protein
undergo
conform
chang
consequ
either
low
endosom
ph
receptor
bind
lead
exposur
hydrophob
peptid
loop
patch
interact
destabil
one
oppos
membran
viral
properti
intracellular
deliveri
viral
fusion
protein
undergo
signific
structur
rearrang
prefus
postfus
conform
lead
format
stabl
hairpin
transmembran
fusion
peptid
domain
end
trimer
elong
rodlik
structur
three
differ
class
viral
fusion
protein
figur
identifi
date
base
common
postfus
structur
follow
class
fusion
protein
character
trimer
hairpin
contain
central
coiledcoil
structur
identifi
orthomyxovirus
paramyxovirus
retrovirus
filovirus
coronavirus
ii
class
ii
fusion
protein
character
trimer
hairpin
compos
structur
main
repres
member
flavivirida
togavirida
famili
iii
class
iii
fusion
protein
central
trimer
core
similar
class
two
fusion
loop
locat
tip
enlong
similar
class
ii
fusion
protein
structur
g
protein
vesicular
stomat
viru
gb
protein
describ
class
iii
fusion
protein
two
glycoprotein
late
ad
class
name
baculoviru
gb
epsteinbarr
viru
despit
structur
differ
among
three
class
induc
membran
fusion
similar
manner
format
analog
hairpin
structur
allow
fusion
peptid
insert
cell
membran
drive
membran
destabil
awesom
refold
step
result
merg
two
lipid
layer
consequ
releas
viral
nucleocapsid
insid
host
cell
nonenvelop
virus
use
differ
mechan
entri
involv
membran
disrupt
pore
format
escap
endosom
abil
disrupt
endosom
membran
allow
releas
genet
materi
insid
cytoplasm
need
directli
depend
capsid
compon
cellular
membran
face
viral
envelop
simpli
protein
made
capsid
process
nonenvelop
virus
entri
gener
start
mechan
reminisc
entri
envelop
virus
name
trigger
conform
chang
capsid
protein
consequ
receptor
bind
ph
lower
conform
chang
allow
releas
viral
compon
membran
lytic
activ
bind
cell
membran
disrupt
lipid
bilay
convey
viral
particl
across
membran
therefor
membran
penetr
mediat
short
membran
alter
amphipat
hydrophob
sequenc
contain
protein
undergon
conform
transit
allow
sequenc
interact
membran
despit
sever
salient
differ
mechan
entri
among
nonenvelop
virus
similar
event
entri
collect
character
membran
lytic
peptid
induc
modif
capsid
protein
result
peptid
exposur
follow
outward
project
peptid
abl
interact
host
membran
disrupt
result
deliveri
viral
genom
insid
host
cell
sever
short
sequenc
deriv
viral
capsid
abl
mediat
entri
identifi
exampl
peptid
lytic
peptid
nodavirus
picornavirus
reovirus
gener
autocatalyt
cleavag
step
precursor
wherea
peptid
deriv
follow
proteolyt
activ
cellular
enzym
case
rotaviru
adenovirus
viral
deriv
proteolysi
addit
peptid
birnaviru
releas
cytosol
virus
viral
capsid
use
cytoplasm
transport
system
cell
move
site
replic
within
cytosol
nucleu
virus
associ
microtubulebas
motor
dynein
dynactin
move
along
microtubul
toward
nucleu
consequ
mani
virus
includ
dna
virus
rna
virus
need
access
nucleu
host
cell
depend
nuclear
protein
ensu
replic
nuclear
envelop
act
barrier
cytoplasm
nucleu
transport
molecul
nucleu
tightli
regul
therefor
virus
develop
sever
strategi
reach
nuclear
milieu
virus
gain
access
nucleu
mitosi
limit
membran
temporarili
disassembl
ii
influenza
viru
other
undergo
extens
disassembl
cytoplasm
cytoplasmicreleas
compon
contain
nuclear
local
sequenc
therebi
abl
cross
nuclear
pore
use
host
transport
machineri
iii
viral
capsid
use
importin
viral
protein
attach
cytoplasm
side
nuclear
pore
interact
nuclear
pore
promot
disassembl
viral
genom
releas
nucleu
iv
viral
capsid
exampl
hepat
b
viru
cross
intact
nuclear
pore
small
size
v
virus
parvovirus
transient
disrupt
nuclear
membran
lamina
enter
nucleu
final
use
cellular
machineri
genom
synthesi
product
new
viral
protein
progeni
virion
assembl
releas
cell
success
clinic
use
nanotechnolog
deliveri
gene
materi
greatli
specif
target
weapon
diseas
cell
thu
reduc
risk
deriv
uptak
normal
tissu
counterpart
overcom
physiolog
barrier
cell
tissu
allow
direct
transfer
across
cell
membran
involv
transient
permeabil
altern
endocytosi
transfer
across
vesicular
membran
lipid
disrupt
pore
format
cell
membran
chang
part
patholog
process
character
viral
infect
propag
viral
genet
content
host
cell
fact
latter
requir
permeabil
cell
membran
order
allow
viral
penetr
alter
intracellular
vesicl
traffick
one
major
limit
strategi
base
transfer
drug
gene
use
nonvir
carrier
poor
side
effect
also
poorli
effici
endosom
vesicl
sequestr
subsequ
fusion
endosom
lysosom
induc
degrad
pharmacolog
activ
moieti
consequ
reduc
efficaci
light
virus
suitabl
tool
order
design
strategi
stealth
endosomallysosom
pathway
consequ
drug
sequestr
peptid
famili
hisrich
peptid
also
shown
complex
dna
effici
deliv
nucleic
acid
eukaryot
cell
phtrigger
lysi
endosom
mani
differ
viral
capsid
membran
protein
peptid
drive
penetr
endosom
escap
depend
upon
differ
class
virus
howev
mechan
involv
regul
biolog
process
common
depend
upon
similar
structur
characterist
viral
moieti
involv
recent
work
identifi
three
distinct
class
viral
membran
fusion
protein
base
follow
structur
criteria
ntermin
class
ii
intern
singl
loop
class
ii
iii
intern
bipartit
loop
class
iii
fusion
peptid
strongli
interact
bilay
undergo
conform
chang
crucial
membran
fusion
report
fusion
peptid
influenza
enhanc
endosom
escap
polyplex
liposomeencapsul
protein
mediat
insert
endosom
membran
mpg
chimer
peptid
compris
two
independ
domain
first
amino
acid
nterminu
deriv
glycinerich
region
viral
hydrophil
cterminu
nuclear
local
signal
simian
viru
larg
antigen
mpg
hydrophob
domain
allow
peptid
insert
membran
mpg
enter
cell
endocytosi
induc
transient
membran
destabil
recent
prove
peptid
deriv
glycoprotein
h
possess
abil
carri
cargo
molecul
across
cell
membran
interact
biolog
membran
contribut
merg
abl
travers
membran
bilay
transport
cargo
cytoplasm
peptid
contain
particular
residu
crucial
capac
interact
target
lipid
membran
particular
rich
hydrophob
residu
allow
peptid
enter
bilay
destabil
membran
fusion
peptid
character
typic
amphipat
structur
mediat
lipidprotein
interact
bind
protein
membran
therebi
trigger
membran
fusion
transloc
confoc
microscopi
studi
live
cell
show
abil
cross
membran
bilay
figur
transloc
cytosol
compar
transactiv
transcript
protein
tat
peptid
mainli
enter
cell
endocytosi
shorter
version
peptid
miss
first
histidin
posit
investig
studi
tu
kim
found
enhanc
transfect
effici
cation
liposom
human
cell
line
improv
intracellular
penetr
liposom
lipoplex
anoth
exampl
suitabl
given
effect
deliveri
intrins
disord
protein
genet
modifi
recombin
prepar
conjug
cprune
cprune
ctermin
domain
hprune
overexpress
breast
colorect
gastric
cancer
interact
multipl
partner
repres
ideal
target
inhibit
cancer
develop
ctermin
domain
result
intrins
disord
domain
easili
transduc
biomembran
due
net
neg
charg
fusion
protein
exhibit
abil
cross
biomembran
open
new
scenario
use
novel
multifunct
carrier
success
use
fusogen
peptid
drug
deliveri
system
depend
specif
target
drug
tumor
cell
minim
toxic
success
new
strategi
treatment
diseas
reli
develop
deliveri
devic
capabl
improv
therapeut
index
biolog
activ
molecul
well
diagnos
diseas
site
interest
fundament
challeng
current
diagnost
therapeut
design
singl
carrier
system
potenti
deliv
therapeut
diseas
site
high
fidel
target
deliveri
allow
diagnosi
cell
deliveri
cell
penetr
uptak
nanotechnolog
potenti
creat
platform
combin
target
deliveri
imag
target
cell
uptak
theranost
sever
class
biomateri
serv
platform
theranost
promis
drug
deliveri
carrier
includ
nanocryst
liposom
virosom
nanoemuls
polym
protein
conjug
nanocomplex
nanoparticl
accord
nanoparticl
versatil
diagnost
therapeut
drug
either
physic
encapsul
coval
conjug
nanoparticl
figur
carrier
composit
shape
surfac
decor
dictat
vivo
behavior
actual
translat
clinic
use
dimens
nanosystem
may
compris
nm
wide
accept
diamet
cancer
therapi
liposom
aggreg
oldest
nanotherapeut
platform
attract
great
attent
due
success
vivo
carrier
hydrophil
entrap
aqueou
core
hydrophob
entrap
within
lipid
membran
drug
liposom
size
rang
mean
diamet
nm
display
uniqu
pharmacokinet
properti
adapt
wide
rang
therapeut
agent
liposom
nontox
biodegrad
nonimmunogen
encapsul
drug
protect
chemic
metabol
degrad
inject
toxic
reduc
thank
decreas
exposur
drug
suscept
healthi
tissu
increas
antitumor
activ
result
rel
long
system
circul
time
achiev
surfac
modif
polyethylen
glycol
polym
extend
exposur
tumor
select
accumul
site
tumor
growth
associ
drug
liposom
markedli
chang
pharmacokinet
pharmacodynam
properti
lower
system
toxic
moreov
order
enhanc
antitumor
efficaci
mani
research
group
also
work
improv
cellular
intern
liposom
addit
surfac
ligand
penetratin
tat
membranotrop
dendrim
hyperbranch
polymer
molecul
nearli
perfect
geometr
architectur
uniqu
branch
topolog
provid
platform
coupl
drug
target
moieti
dendrim
gener
increas
end
group
peripheri
becom
close
pack
allow
achiev
concentr
payload
drug
spectroscop
label
therapeut
imag
applic
order
enhanc
cellular
uptak
dendrim
coupl
cation
cellpenetr
peptid
well
membranotrop
peptid
core
nanoparticl
also
common
platform
nanobiosystem
construct
core
materi
may
display
uniqu
properti
stabil
detect
nanoparticl
differ
shape
composit
develop
includ
synthet
natur
polym
inorgan
materi
iron
oxid
quantum
dot
gold
numer
group
work
novel
multicompon
carrier
use
packag
strategi
mimic
virus
obtain
mere
linear
fusion
compon
includ
multifunct
fusion
protein
use
signal
transport
domain
divers
organ
assembl
singl
protein
favaro
et
al
recent
report
obtain
multifunct
protein
deriv
fusion
recombin
human
dynein
light
chain
ntermin
dna
bind
domain
ctermin
tat
sequenc
multifunct
fusion
protein
intend
mimic
viral
vector
take
advantag
microtubul
faster
intracellular
movement
toward
nucleu
hatakeyama
et
al
demonstr
introduct
phsensit
fusogen
glutam
acidalanineleucinealanin
repeat
peptid
gala
peptid
pegpeptidedop
conjug
ppd
facilit
nanoparticl
endosom
escap
therebi
enhanc
effici
sirna
deliveri
gene
silenc
elsay
et
al
describ
novel
stearyl
deriv
endosomedisrupt
peptid
deriv
influenza
viru
hemagglutinin
protein
allow
prepar
multifunct
envelopetyp
nano
devic
mimic
structur
influenza
viru
new
nanocarri
platform
base
natur
biolog
build
block
offer
great
promis
develop
varieti
applic
nanotechnolog
typic
exampl
natur
molecular
assembl
contain
repres
virusbas
nanoparticl
nanocag
nanorod
assembl
capsid
protein
virus
obtain
exploit
recent
rapid
advanc
protein
engin
materi
scienc
viruslik
particl
vlp
multisubunit
protein
complex
abl
selfassembl
form
higherord
structur
mimick
nativ
conform
virus
main
differ
nativ
virus
vlp
carri
hidden
capsid
protect
shell
viral
genet
materi
empti
case
incorpor
select
piec
genet
materi
therefor
vlp
lack
complet
viral
genom
unabl
replic
noninfecti
last
three
decad
vlp
demonstr
use
product
safe
vaccin
first
vaccin
approv
food
drug
administr
vaccin
hepat
b
viru
mani
point
view
vlp
indistinguish
vnp
fact
basic
strategi
behind
product
vlp
vnp
exactli
genet
engin
capsid
protein
express
microbi
factori
eg
bacteria
yeast
insect
cell
mammalian
cell
plant
princip
differ
vnp
intend
creat
novel
materi
appli
broader
field
nanotechnolog
solv
differ
materialbas
problem
scope
present
review
drug
deliveri
appropri
size
gener
rang
nm
homogen
possibl
function
easi
modif
chemic
genet
rout
possibl
conveni
prepar
scale
microbi
factori
vnp
emerg
promis
platform
gene
drug
deliveri
applic
plant
anim
virus
also
bacteriophag
employ
produc
vnp
princip
plant
virus
includ
tobacco
mosaic
viru
tmv
brome
mosaic
viru
cowpea
chlorot
mottl
viru
ccmv
red
clover
necrot
mosaic
viru
wherea
anim
virus
princip
repres
alphaviru
polyoma
jc
viru
adenoviru
phage
bacteriophag
also
explor
construct
vnp
tabl
mainli
two
way
design
vnpcarri
pharmaceut
molecul
heterogen
genet
materi
cargo
therapeut
cargo
encapsul
insid
capsid
ii
therapeut
cargo
attach
surfac
nanoparticl
figur
sever
virus
prove
amen
chemic
genet
manipul
inner
caviti
well
outer
surfac
attach
drug
molecul
render
feasibl
tool
molecular
biolog
allow
engin
capsid
protein
subunit
modifi
amino
acid
residu
key
posit
within
assembl
structur
allow
precis
spatial
numer
control
reactiv
function
group
chemic
attach
ligand
plant
viru
cowpea
mosaic
viru
cpmv
coval
modif
link
doxorubicin
anticanc
drug
capsid
shell
explor
potenti
applic
anticanc
therapi
doxorubicin
conjug
stabl
amid
bond
cpmv
carrier
system
formul
induc
timedelay
enhanc
toxic
hela
cell
compar
free
drug
plant
virus
use
creat
vnp
carrier
doxorubicin
red
clover
necrot
mosaic
viru
hibiscu
chlorot
ringspot
viru
vnp
load
doxorubicin
arm
target
peptid
deliv
hela
cell
cytotox
effect
observ
investig
biodistribut
clearanc
nontarget
ccmv
member
bromovirida
famili
show
broad
distribut
movement
throughout
mice
tissu
organ
rapid
excret
absenc
long
term
persist
within
tissu
organ
toxic
singl
inject
suggest
possibl
use
ccmv
safe
biocompat
nanoplatform
applic
biomedicin
accur
diagnosi
inflammatori
diseas
molecular
imag
becom
necess
plant
viral
nanoparticl
platform
base
tmv
explor
order
target
vascular
cell
adhes
highli
express
activ
endotheli
cell
atherosclerot
plaqu
tmv
modifi
carri
nearinfrar
dye
chelat
gd
ion
build
multimod
probe
magnet
reson
optic
imag
use
atherosclerot
apoemous
model
obtain
result
indic
molecular
target
atherosclerot
plaqu
case
anim
virus
main
exampl
vnp
construct
provid
jc
viru
adenoviru
jc
polyomaviru
employ
realiz
drugreleas
vnp
releas
mechan
trigger
chang
ph
vnp
compos
major
coat
protein
inner
core
protein
use
anchor
hexahistidin
motif
tag
insid
vnp
tag
allow
specif
revers
attach
drug
molecul
enter
nm
pore
present
vnp
releas
ph
lower
consequ
proton
histidin
dodecahedron
base
adenoviru
compos
copi
pentamer
viral
protein
respons
viru
penetr
use
deliv
lipophil
nonperm
labil
anticanc
antibiot
bleomycin
blm
success
blm
deliveri
vector
consist
significantli
improv
drug
bioavail
importantli
adenoviru
dodecahedron
form
vnp
much
smaller
virion
differ
intraparticl
interact
final
also
bacteriophag
use
product
deliveri
vector
bacteriophag
vnp
abl
select
deliv
nanoparticl
chemotherapeut
drug
sirna
cocktail
protein
toxin
human
hepatocellular
carcinoma
hcc
vnp
modifi
peptid
bind
hcc
deliv
high
concentr
encapsid
cargo
cytosol
hcc
cell
vnp
load
doxorubicin
cisplatin
select
kill
hcc
cell
line
nanomolar
concentr
vnp
encapsid
sirna
cocktail
silenc
express
cyclin
famili
member
induc
growth
arrest
apoptosi
picomolar
concentr
show
vnp
easili
modifi
specif
encapsid
varieti
dispar
cargo
induc
select
cytotox
cancer
vitro
figur
viral
capsid
nanocarri
transport
bioactiv
molecul
surfac
intern
core
intracellular
uptak
drug
nucleic
acid
treatment
human
diseas
import
challeng
medicin
requir
multidisciplinari
effort
order
success
nanotechnolog
increasingli
use
order
design
develop
nanometr
carrier
deliveri
therapeut
agent
diseas
tissu
cell
teach
come
viru
world
could
enorm
use
order
enhanc
deliveri
potenti
nanocarri
virus
natur
evolv
nanoparticl
abl
effici
deliv
genet
materi
physiolog
barrier
cellular
membran
mechan
virus
infect
cell
cross
membran
could
extrem
use
order
design
strategi
base
upon
use
viral
capsid
nanocarri
decor
nanocarri
cellpenetr
peptid
viral
origin
strategi
could
success
favor
deliveri
diseas
tissu
favor
penetr
diseas
cell
tight
interact
differ
biomed
scientist
microbiologist
biochemist
chemist
pharmacologist
medic
doctor
could
repres
way
see
light
end
tunnel
effici
deliv
drug
diseas
tissu
spare
normal
counterpart
